Honeywell confirmed its fiscal 2026 adjusted earnings per share forecast of $10.35 to $10.65 and sales guidance of $38.8 billion to $39.8 billion, aligning closely with analyst expectations. The company also provided a preliminary outlook for Honeywell Technologies, the business remaining after the aerospace spin-off, projecting sales of about $20 billion and adjusted EPS growth of 22% to 28%. This update precedes Honeywell's investor conference and reflects ongoing portfolio changes including divestitures and acquisitions. The stock is currently facing some technical pressure but holds long-term support near $213.
The global surgical masks market, valued at $3.95 billion in 2024, is projected to grow at a 5.5% CAGR to reach $6.76 billion by 2034. Growth is driven by increased healthcare applications, rising infection control awareness, and more surgical proced...
Honeywell confirmed its full-year 2026 financial guidance before spinning off its Aerospace division on June 29, 2026. The company expects total sales between $38.8 billion and $39.8 billion, with adjusted earnings per share rising 6% to 9%. Post spi...
Honeywell announced that it will spin off its Aerospace division on June 29, 2026, distributing one share of Honeywell Aerospace stock for every two shares of Honeywell stock held as of June 15, 2026. Honeywell Aerospace will begin trading on Nasdaq ...
The HON Company has launched a new 12,000-square-foot flagship showroom in Chicago, designed as an immersive workplace and learning environment. The showroom integrates HON's portfolio across four zones—The Commons, The Sandbox, The Hub, and The Educ...
Quantinuum, formed by merging Honeywell's quantum division and Cambridge Quantum, debuted on Nasdaq at $68 per share, raising $1.68 billion in an upsized IPO. The company, valued at about $17.6 billion, offers full-stack quantum computing hardware an...
